NURS 5433 Module 2 Respiratory Exam
UPDATED ACTUAL QUESTIONS AND
CORRECT ANSWERS
ICS - CORRECT ANSWER Inhaled corticosteroids used for asthma management.
Low ICS - CORRECT ANSWER *Budesonide: 180-360 mcg/day (Pulmicort) and
Fluticasone propionate: 100-250 mcg/day (Flovent)
Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day
Medium ICS - CORRECT ANSWER • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day
High ICS - CORRECT ANSWER • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
• Mometasone: >440 mcg/day
SABA - CORRECT ANSWER Short-acting beta agonists such as salbutamol
(albuterol) and terbutaline.
LAMA - CORRECT ANSWER Long-acting muscarinic antagonists like tiotropium
and beclomethasone-formoterol glycopyrronium.
, LABA - CORRECT ANSWER Long-acting beta agonists such as salmeterol and
formoterol.
ICS and LABA combo - CORRECT ANSWER Combination medications like
beclomethasone/formoterol and budesonide/formoterol.
SAMA - CORRECT ANSWER Short-acting muscarinic antagonists such as
ipratropium bromide and oxitropium bromide (combo with SABA).
Oral corticosteroids - CORRECT ANSWER Prednisone, prednisolone, and
methylprednisolone.
Anti-IgE - CORRECT ANSWER Omalizumab, a medication used for asthma
management.
Leukotriene modifiers (LTRA) - CORRECT ANSWER Medications such as
montelukast, pranlukast, and zileuton.
Sustained step-up treatment - CORRECT ANSWER Increase treatment for at least 2-3
months if symptoms persist despite controller treatment.
Common issues to consider before stepping up asthma tx - CORRECT
ANSWER Incorrect inhaler technique, poor adherence, modifiable risk (smoking)
Short-term step-up treatment - CORRECT ANSWER Temporary increase in treatment
for 1-2 weeks during exacerbations.
Day-to-day adjustment - CORRECT ANSWER Using as-needed low dose ICS-
formoterol for mild asthma or ICS-formoteral as a maintenance and reliever therapy.
Stepping down treatment - CORRECT ANSWER Reduce treatment once good asthma
control has been achieved for 3 months.
UPDATED ACTUAL QUESTIONS AND
CORRECT ANSWERS
ICS - CORRECT ANSWER Inhaled corticosteroids used for asthma management.
Low ICS - CORRECT ANSWER *Budesonide: 180-360 mcg/day (Pulmicort) and
Fluticasone propionate: 100-250 mcg/day (Flovent)
Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day
Medium ICS - CORRECT ANSWER • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day
High ICS - CORRECT ANSWER • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
• Mometasone: >440 mcg/day
SABA - CORRECT ANSWER Short-acting beta agonists such as salbutamol
(albuterol) and terbutaline.
LAMA - CORRECT ANSWER Long-acting muscarinic antagonists like tiotropium
and beclomethasone-formoterol glycopyrronium.
, LABA - CORRECT ANSWER Long-acting beta agonists such as salmeterol and
formoterol.
ICS and LABA combo - CORRECT ANSWER Combination medications like
beclomethasone/formoterol and budesonide/formoterol.
SAMA - CORRECT ANSWER Short-acting muscarinic antagonists such as
ipratropium bromide and oxitropium bromide (combo with SABA).
Oral corticosteroids - CORRECT ANSWER Prednisone, prednisolone, and
methylprednisolone.
Anti-IgE - CORRECT ANSWER Omalizumab, a medication used for asthma
management.
Leukotriene modifiers (LTRA) - CORRECT ANSWER Medications such as
montelukast, pranlukast, and zileuton.
Sustained step-up treatment - CORRECT ANSWER Increase treatment for at least 2-3
months if symptoms persist despite controller treatment.
Common issues to consider before stepping up asthma tx - CORRECT
ANSWER Incorrect inhaler technique, poor adherence, modifiable risk (smoking)
Short-term step-up treatment - CORRECT ANSWER Temporary increase in treatment
for 1-2 weeks during exacerbations.
Day-to-day adjustment - CORRECT ANSWER Using as-needed low dose ICS-
formoterol for mild asthma or ICS-formoteral as a maintenance and reliever therapy.
Stepping down treatment - CORRECT ANSWER Reduce treatment once good asthma
control has been achieved for 3 months.
